Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo ...

Phase 2 data presented at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting show deep and durable tumor regressions in heavily pre-treated melanoma patients, with a mild safety ...

Therapeutics presented new data from the ongoing REZOLVE-AD Phase 2b study in a late-breaking oral abstract presentation at the ...

Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...

From silver nanofibers to smart, sensory-packed dressings, the next generation of wound-healing technology is blurring the ...

SITC abstracts highlight updated immunogenicity results from the Phase 2 AMPLIFY-7P trial of ELI-002 7P and preclinical data on the use of ...

At times, aging doesn’t become evident in wrinkles or in gray hair, it occurs deep inside your body, in cells that have ...

Having a cell phone nowadays is an essential part of life. It's what we use to communicate with others and stay in the know, ...

The company plans to install over 200 fuel cells at its facility off Scioto Darby Creek Road. According to the City of ...

Rosnilimab acts as an agonist to stimulate PD-1, killing those cells with high PD-1 expression and pushing others into an ...